Biotricity, Inc.
Biotricity, Inc. (BTCY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BTCY · as of Jun 9, 2026
Key Statistics
Explore Biotricity, Inc. Data
btcy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
The BTCY analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing +3233.33% upside from the current price of $0.12.
Competitors & Peers
btcy competitorsBTCY
ALRTF
ASAPF
CLCS
CRVW
GLABFStock Performance
Full HistoryAbout Biotricity, Inc.
Biotricity, Inc. Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts…
what is biotricity, inc. · btcy stock overview · biotricity, inc. company profile · who is biotricity, inc. ceo · btcy OTC · biotricity, inc. headquarters · biotricity, inc. business segments
About Stock Overview & Key Data
Biotricity, Inc. (BTCY) is a Healthcare company in the Medical - Devices industry, listed on OTC since Feb 16, 2018. As of the latest trading session, BTCY stock price is $0.12, with a market capitalization of $3.4M. The stock has returned -76.00% over the past 12 months and -60.00% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Biotricity, Inc. stock is Buy, with an average 12-month price target of $4.00. In fiscal year 2025, Biotricity, Inc. reported revenue of $13.8M and net income of -$8.4M. For detailed data — including Biotricity, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biotricity, Inc. (BTCY) stock price is $0.12. The stock is traded on OTC under the ticker symbol BTCY. The 52-week range is $0.10 – $0.75.